Search Login Register
Bacteremia
Summary
4011
relevant articles (304 outcomes,
388 trials/studies)
found for this Disease
Description:
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
Also Known As:
Bacteremias
Key Drugs and Agents for Bacteremia
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Anti-Bacterial Agents (Antibiotics)
:
24 outcomes 26 studies in 377 results
: IBA
-
Vancomycin
:
17 outcomes 29 studies in 246 results
:
FDA 18
Generic
-
Antibodies
:
17 outcomes 5 studies in 86 results
: IBA
-
Gentamicins (Gentamicin)
:
13 outcomes 7 studies in 91 results
:
FDA 60
Generic
-
Ciprofloxacin (Cipro)
:
11 outcomes 6 studies in 74 results
:
FDA 52
Generic
-
Amikacin (A.M.K)
:
9 outcomes 8 studies in 41 results
:
FDA 20
Generic
-
Clarithromycin (Biaxin)
:
9 outcomes 8 studies in 34 results
:
FDA 22
Generic
-
Penicillins (Penicillin)
:
9 outcomes 7 studies in 107 results
:
FDA 1
-
Antigens
:
9 outcomes 4 studies in 68 results
: IBA
-
Rifabutin (Ansamycin)
:
8 outcomes 12 studies in 31 results
:
FDA 1
Show All >>
Diseases Related to Bacteremia
-
Infection
-
Meningitis
-
Pneumonia (Pneumonitis)
-
Sepsis (Septicemia)
-
Endocarditis
Show All >>
Key Therapies for Bacteremia
Efficacy Chart >>
-
Renal Dialysis (Hemodialysis)
:
4 outcomes 20 studies in 171 results
-
Drug Therapy (Chemotherapy)
:
4 outcomes 7 studies in 89 results
-
Splenectomy
:
4 outcomes 2 studies in 23 results
-
Ligation
:
2 outcomes 4 studies in 20 results
-
Bone Marrow Transplantation (Transplantation, Bone Marrow)
:
2 outcomes 2 studies in 25 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.